Other
(Ferric Sulphate)
(Ferric Sulphate) is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
COMBINATION PRODUCT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (33.3%)
N/A2 (66.7%)
Trials by Status
enrolling_by_invitation133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_3
Laser Pulpotomy: a Modern-non Pharmacological Alternate to Ferric Sulphate Pulpotomy
NCT07522268
enrolling_by_invitationnot_applicable
Effect of Ferric Sulphate and Putty MTA as Pulpotomy Agent in Vital Primary Teeth
NCT07324928
completednot_applicable
Pulpotomy With Various MTA Materials and Ferric Sulphate
NCT03718676
Clinical Trials (3)
Showing 3 of 3 trials
NCT07522268Phase 3
Laser Pulpotomy: a Modern-non Pharmacological Alternate to Ferric Sulphate Pulpotomy
NCT07324928Not Applicable
Effect of Ferric Sulphate and Putty MTA as Pulpotomy Agent in Vital Primary Teeth
NCT03718676Not Applicable
Pulpotomy With Various MTA Materials and Ferric Sulphate
All 3 trials loaded
Drug Details
- Intervention Type
- COMBINATION PRODUCT
- Total Trials
- 3